21 results
Cote d'Ivoire:Using rumor management system data to develop adaptive COVID- 19 vaccination strategies
Cote d'ivoire: Innovative and effective strategies of enhancing vaccine confidence and uptake and risk communication and community engagement with an emphasis on high-risk and vulnerable groups
Cote d'Ivoire_Using rumor management system data to develop adaptive COVID-19 vaccination strategies
Cote d'Ivoire: Risk communication stakeholders need access to timely, focused information on public sentiment and rumors
The BID Learning Network (BLN) invites you to watch our webinar entitled “Integration of a Community-Based Early Warning System Module into DHIS2 in Cote d’Ivoire.” Recognizing the need to...
The Polio Eradication and Endgame Strategic plan outlines the phased removal of oral polio vaccines (OPVs), starting with type 2 poliovirus–containing vaccine and introduction of inactivated polio...
Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was...
Background
As part of the efforts to eradicate polioviruses in the African Region, structures were put in place to ensure coordinated mobilization and deployment of resources within the framework...
Introduction
Vitamin A deficiency is a public health problem that affects children across the WHO African Region. Countries have integrated vitamin A supplementation in different child health...
Background
Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Introduction
The PEI Programme in the WHO African region invested in recruitment of qualified staff in data management, developing data management system and standards operating systems since the...
The laboratory has always played a very critical role in diagnosis of the diseases. The success of any disease programme is based on a functional laboratory network. Health laboratory services are an...
Introduction
Recently we have recorded some progress against the transmission of poliovirus in the African Region. This is attributable to a number of factors, including commitment of global...
MenAfriVacTM is the first of the World Health Organization (WHO)’s pre-qualified vaccines to be allowed to mass vaccination campaign at a temperature below or equal to 40°C during 4 days. This new...
The BLN is a platform for peer learning and information exchange intended to enable strong
collaborative links between peers from different countries in support of improved data...
The following report displays data and figures on the introduction status of Hib vaccine, pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV)* both globally...
The annual progress report gives a comprehensive overview of the activities and performance of Gavi, the Vaccine Alliance, illustrating the work and achievements of this public-private partnership.
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...